Loading...
Factor XIa inhibitors: A review of patent literature
INTRODUCTION: Anticoagulants are the mainstay for prevention and/or treatment of thrombotic disorders. Each clinically used anticoagulant is associated with significant adverse consequences, especially bleeding. Factor XIa (FXIa), a key factor involved in the amplification of procoagulation signal,...
Saved in:
| Published in: | Expert Opin Ther Pat |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4941829/ https://ncbi.nlm.nih.gov/pubmed/26881476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543776.2016.1154045 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|